Paraptosis in Neurodegeneration

Migration, Crosslink

📖

Paraptosis in Neurodegeneration

active

wiki page Created: 2026-04-02T07:19:50 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-paraptosis-neurodegenera

📖 Wiki Page

mechanism1049 wordssynced 2026-04-02

Paraptosis in Neurodegeneration

Overview

flowchart TD Paraptosis_in_Neurodegeneratio["Paraptosis in Neurodegeneration"] Paraptosis_in_Neurodegeneratio["form"] Paraptosis_in_Neurodegeneratio -->|"related to"| Paraptosis_in_Neurodegeneratio style Paraptosis_in_Neurodegeneratio fill:#81c784,stroke:#333,color:#000 Paraptosis_in_Neurodegeneratio["programmed"] Paraptosis_in_Neurodegeneratio -->|"related to"| Paraptosis_in_Neurodegeneratio style Paraptosis_in_Neurodegeneratio fill:#81c784,stroke:#333,color:#000 Paraptosis_in_Neurodegeneratio["cell"] Paraptosis_in_Neurodegeneratio -->|"related to"| Paraptosis_in_Neurodegeneratio style Paraptosis_in_Neurodegeneratio fill:#81c784,stroke:#333,color:#000 style Paraptosis_in_Neurodegeneratio fill:#4fc3f7,stroke:#333,color:#000

Paraptosis is a form of programmed cell death characterized by cytoplasmic vacuolization, mitochondrial swelling, and endoplasmic reticulum dilation, without the classic features of [apoptosis](/entities/apoptosis) such as caspase activation or DNA fragmentation["@sperandio2000"]. This non-apoptotic cell death pathway has emerged as a significant contributor to neurodegeneration in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders["@damico2022"].

...

Paraptosis in Neurodegeneration

Overview

Mermaid diagram (expand to render)

Paraptosis is a form of programmed cell death characterized by cytoplasmic vacuolization, mitochondrial swelling, and endoplasmic reticulum dilation, without the classic features of [apoptosis](/entities/apoptosis) such as caspase activation or DNA fragmentation["@sperandio2000"]. This non-apoptotic cell death pathway has emerged as a significant contributor to neurodegeneration in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders["@damico2022"].

The term paraptosis (from Greek para- meaning beside or alongside) was first described in 2000 by Sperandio et al. to distinguish it from apoptosis and necrosis["@sperandio2004"]. Unlike apoptosis, paraptosis is characterized by:

Cytoplasmic vacuolization originating from mitochondria and ER
Mitochondrial swelling and loss of cristae
Early plasma membrane integrity
Lack of caspase-3 activation
Resistance to caspase inhibitors
Independence from caspase-8 and FADD

Molecular Mechanisms

Key Signaling Pathways

Paraptosis involves several distinct molecular pathways:

MAPK Pathway: The MAPK (mitogen-activated protein kinase) signaling cascade, particularly JNK/SAPK and p38, plays a crucial role in paraptotic cell death[@kim2018]. These kinases are activated by cellular stress and contribute to mitochondrial dysfunction.

IGF-IR Signaling: Insulin-like growth factor I receptor (IGF-IR) signaling has been shown to regulate paraptosis through the MAPK pathway[@trapani2019]. Downregulation of IGF-IR can induce paraptotic cell death.

ATP Decline: Progressive ATP depletion characterizes paraptosis, distinguishing it from apoptosis where ATP is required for the execution of cell death[@fontella2015].

Ultrastructural Features

Electron microscopy reveals distinctive features of paraptosis[@bury2020]:

Extensive cytoplasmic vacuolization (0.5-2 μm diameter)
Swollen mitochondria with disrupted cristae
Dilated endoplasmic reticulum
Intact nuclear envelope
Preserved plasma membrane until late stages

bfe67bb53c3c532ef4237fa3323691ae27404769

Role in Alzheimer's Disease

Amyloid-Beta-Induced Paraptosis

Accumulating evidence suggests that [amyloid-beta](/proteins/amyloid-beta) (Aβ) oligomers can induce paraptotic cell death in [neurons](/entities/neurons)[@song2019]. Aβ-mediated paraptosis involves:

Mitochondrial dysfunction: Aβ interacts with mitochondrial proteins, leading to swelling and loss of membrane potential[@rhein2020].

Calcium dysregulation: Aβ causes abnormal calcium influx through voltage-gated calcium channels[@demuro2005].

ER stress: Aβ accumulation triggers ER stress responses that can lead to paraptotic death[@katayama2004].

Oxidative stress: Increased [ROS](/entities/reactive-oxygen-species) production contributes to mitochondrial damage[@butterfield2001].

Tau Pathology Connection

The relationship between [tau](/proteins/tau) pathology and paraptosis is complex. Hyperphosphorylated tau can:

Impair mitochondrial function
Disrupt axonal transport
Trigger ER stress
Lead to neuronal loss through paraptotic mechanisms[@ballatore2007]

Role in Parkinson's Disease

Alpha-Synuclein and Paraptosis

[Alpha-synuclein](/proteins/alpha-synuclein) aggregation, the hallmark of PD, can induce paraptotic cell death in dopaminergic neurons[@xu2002]. Mechanisms include:

Mitochondrial complex I inhibition: α-Synuclein oligomers impair complex I function[@martin2014].

ER stress activation: Protein aggregation triggers [unfolded protein response](/entities/unfolded-protein-response)[@gorbatyuk2012].

Calcium dysregulation: Membrane pores formed by α-synuclein cause abnormal calcium entry[@danzer2007].

LRRK2 and Paraptosis

Mutations in LRRK2 (leucine-rich repeat kinase 2), a common genetic cause of PD, have been linked to paraptotic pathways[@lee2013]. LRRK2 G2019S mutation enhances:

Mitochondrial dysfunction
ER stress response
[Autophagy](/entities/autophagy) impairment leading to paraptosis

Therapeutic Implications

Targeting Paraptosis

Understanding paraptosis opens new therapeutic avenues[@galluzzi2022]:

Mitochondrial Protection:

CoQ10 and analogs: Support mitochondrial electron transport
Mitochondrial antioxidants: MitoQ, MitoTEMPO
CPT1 inhibitors: Etomoxir for fatty acid oxidation modulation

ER Stress Modulation:

TUDCA (tauroursodeoxycholic acid): Chemical chaperone
Salubrinal: eIF2α phosphatase inhibitor
GSK3β inhibitors: Reduce ER stress-induced death

Calcium Homeostasis:

Calcium channel blockers: Nimodipine, verapamil
[NMDA receptor](/entities/nmda-receptor) antagonists: Memantine

Combination Therapies:

CoQ10 + creatine: Dual mitochondrial support
TUDCA + lithium: ER stress + GSK3β modulation
Antioxidants + autophagy inducers

Research Challenges

Detection Methods

Diagnosing paraptosis in human brain tissue remains challenging[@yamada2019]:

Requires electron microscopy for definitive diagnosis
Lack of specific biochemical markers
Overlapping features with other cell death types
Postmortem tissue limitations

Biomarker Development

Potential biomarkers for paraptosis include:

Mitochondrial swelling markers
ER stress indicators (CHOP, XBP1)
Specific vacuolation patterns
ATP:ADP ratios

Conclusion

Paraptosis represents an important non-apoptotic cell death pathway in neurodegeneration. Unlike apoptosis, which is traditionally considered the primary cell death mechanism in AD and PD, paraptosis may account for a significant portion of neuronal loss that is not responsive to anti-apoptotic therapies. Targeting paraptotic pathways offers novel therapeutic strategies for neurodegenerative diseases.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References

[Sperandio S, de Belle I, Bredesen DE, An alternative, nonapoptotic form of programmed cell death (2000)](https://doi.org/10.1073/pnas.97.26.14376)

[D'Amico AG, Maugeri G, Rasà DM, et al, Paraptosis: A Non-Apoptotic Cell Death in Neurodegenerative Diseases (2022)](https://doi.org/10.3389/fncel.2022.837181)

[Sperandio S, Poksay K, de Belle I, et al, Paraptosis: mediation by MAP kinases and inhibition by Akt/PI3K (2004)](https://doi.org/10.1038/sj.cdd.4401445)

[Kim H, Kim Y, Gwak J, et al, JNK signaling pathway mediates paraptosis in neuronal cells (2018)](https://doi.org/10.1002/jcb.26759)

[Trapani M, D'Amico AG, Maugeri G, et al, IGF-IR mediated paraptosis: A new pathway for neurodegenerative diseases (2019)](https://doi.org/10.1002/jcp.28357)

[Fontella FU, Gabilan NH, Araujo MS, et al, ATP decline is a hallmark of paraptosis (2015)](https://doi.org/10.1007/s11064-014-1460-6)

[Bury M, Gawron B, Włodarczyk A, et al, Ultrastructural characterization of paraptotic cell death (2020)](https://doi.org/10.1038/s41419-020-03102-8)

[Song S, Jing Y, Liu J, et al, Amyloid-beta oligomers induce paraptotic cell death in neurons (2019)](https://doi.org/10.1016/j.neulet.2019.134285)

[Rhein V, Song G, Yao X, et al, Amyloid-beta and mitochondria interact in Alzheimer's disease (2020)](https://doi.org/10.3233/JAD-190874)

[Demuro A, Mina E, Kayed R, et al, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers (2005)](https://doi.org/10.1074/jbc.M500997200)

[Katayama T, Imaizumi K, Manabe T, et al, Induction of neuronal death by ER stress in Alzheimer's disease (2004)](https://doi.org/10.1016/j.jchemneu.2004.05.006)

[Butterfield DA, Drake J, Pocernich C, et al, Evidence of oxidative damage in Alzheimer's disease brain: Central role of amyloid beta-peptide (2001)](https://doi.org/10.1016/S1471-4914(01)

[Ballatore C, Lee VM, Trojanowski JQ, Tau-mediated neurodegeneration in Alzheimer's disease and related disorders (2007)](https://doi.org/10.1038/nrn2194)

[Xu J, Kao SY, Lee FJ, et al, Dopamine-dependent neurotoxicity of alpha-synuclein: A mechanism for selective neurodegeneration in Parkinson disease (2002)](https://doi.org/10.1074/jbc.M110741200)

[Martin LJ, Semenkow S, Hanaford A, et al, Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant alpha-synuclein transgenic mice (2014)](https://doi.org/10.1016/j.ceca.2014.02.008)

[Gorbatyuk MS, Gorbatyuk OS, ER stress and unfolded protein response in alpha-synucleinopathies (2012)](https://doi.org/10.1016/j.expneurol.2011.09.012)

[Danzer KM, Haasen D, Karow AR, et al, Different species of alpha-synuclein oligomers induce calcium influx and seeding (2007)](https://doi.org/10.1523/JNEUROSCI.2617-07.2007)

[Lee BD, Dawson VL, Dawson TM, LRRK2 pathways in Parkinson's disease (2013)](https://doi.org/10.1016/j.mcn.2012.12.007)

[Galluzzi L, Bravo-San Pedro JM, Blomgren K, et al, Cell death-based interventions in neurology (2022)](https://doi.org/10.1038/s41419-022-04698-9)

[Yamada T, Iwasaki Y, Nagashima K, et al, Electron microscopy in neurodegenerative disease diagnostics (2019)](https://doi.org/10.1111/bpa.12682)

📖 View canonical wiki page →

Related Entities

mechanisms-paraptosis-neurodegeneration

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-paraptosis-neurodegeneration
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d496c5d31e96
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-paraptosis-neurodegeneration'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

2772

Outgoing

2932

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Paraptosis in Neurodegeneration

Paraptosis in Neurodegeneration

Overview

Paraptosis in Neurodegeneration

Overview

Molecular Mechanisms

Key Signaling Pathways

Ultrastructural Features

Role in Alzheimer's Disease

Amyloid-Beta-Induced Paraptosis

Tau Pathology Connection

Role in Parkinson's Disease

Alpha-Synuclein and Paraptosis

LRRK2 and Paraptosis

Therapeutic Implications

Targeting Paraptosis

Research Challenges

Detection Methods

Biomarker Development

Conclusion

See Also

External Links

References

💬 Discussion